Letters to the Editor
Antidepressants in pregnancy
- Felicity Prior, Anne Sved Williams
- Aust Prescr 2008;31:32
- 1 April 2008
- DOI: 10.18773/austprescr.2008.017
The Editorial Executive Committee welcomes letters, which should be less than 250 words. Before a decision to publish is made, letters which refer to a published article may be sent to the author for a response. Any letter may be sent to an expert for comment. When letters are published, they are usually accompanied in the same issue by their responses or comments. The Committee screens out discourteous, inaccurate or libellous statements. The letters are sub-edited before publication. Authors are required to declare any conflicts of interest. The Committee's decision on publication is final.
Editor, – Current research and information is essential in determining the need for pharmacotherapy of depression during pregnancy and postpartum (Aust Prescr 2007;30:125-7). Therapeutic Guidelines provides a framework for practitioners to address the decision of whether or not to prescribe a psychotropic drug. This includes the risks of prescribing as well as the risks of not prescribing.1
Another useful resource is the Therapeutic Advice and Information Service (TAIS), which is funded by the National Prescribing Service. By calling 1300 138 677, health professionals can obtain advice regarding individual patients in a timely manner. This information is provided by drug information pharmacists with access to current medical literature and clinical training to assist with questions relating to drug use during pregnancy and lactation.
Director, Hunter Drug Information Service
Calvary Mater Newcastle
On behalf of the Therapeutic Advice and Information Service
Director, Hunter Drug Information Service Calvary Mater Newcastle NSW
Clinical Senior Lecturer, University of Adelaide
Director, Perinatal and Infant Mental Health Services, Children, Youth and Women's Health Services, South Australia